LBF20406AM06: Difference between revisions

← Older edit

Latest revision as of 13:40, 21 October 2010

LipidBank Top
(トップ)

Fatty acid
(脂肪酸)

Glycerolipid
(グリセロ脂質)

Sphingolipid
(スフィンゴ脂質)

Journals
(雑誌一覧)

How to edit
(ページの書き方)

Upper classes: LB LBF

Arachidonoylamide

Structural Information
	(cis-5,cis-8,cis-11,cis-14) -Eicosatetraenoylamine
	Arachidonoylamide (5Z,8Z,11Z,14Z) -Eicosatetraenoylamine

Formula	C20H33NO
Exact Mass	303.256214683
Average Mass	303.48215999999996
SMILES	`C(CC=CCC=CCC=CCC=CCCCC(N)=O)CCC`
Physicochemical Information
	colorless oil Sheskin_T et al.






	This compound was synthesized from arachidonyl chloride and ammonium hydroxide. Yield is 80 %. Sheskin_T et al.

	Binding of this compound to the brain cannabinoid receptor (CBl),Ki (nM)>1000 Sheskin_T et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra	¹H NMR (CDCl3) δ 5.82 (br s, lH), 5.31-5.42 (m, 8H), 2.79-2.85 (m, 6H), 2.23 (t, J=8.1Hz, 2H), 2.04-2.15 (m, 4H), 1.70-1.77 (m, 2H), 1.25-1.38 (m, 6H), 0.89 (t, J=6.8Hz,3H). Sheskin_Tet al.
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20406AM06	See above.	Sheskin_T et al. 1997

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
 {{Metabolite
 |LipidBank=XPR7022
-|LipidMaps=LMFA08020008
+|LipidMaps=LMFA08010007
-|SysName=arachidonoyl amide
+|SysName=(cis-5,cis-8,cis-11,cis-14) -Eicosatetraenoylamine
-|Common Name=&&arachidonoyl amide&&
+|Common Name=&&Arachidonoylamide&&(5Z,8Z,11Z,14Z) -Eicosatetraenoylamine&&
 |Melting Point=colorless oil [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
-|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H NMR (CDCl3) <FONT FACE="Symbol">d</FONT>5.82 (br s, lH), 5.31-5.42 (m, 8H), 2.79-2.85 (m, 6H), 2.23 (t, J=8.1Hz, 2H), 2.04-2.15 (m, 4H), 1.70-1.77 (m, 2H), 1.25-1.38 (m, 6H), 0.89 (t, J=6.8Hz,3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|NMR Spectra=^1 H NMR (CDCl3)  delta 5.82 (br s, lH), 5.31-5.42 (m, 8H), 2.79-2.85 (m, 6H), 2.23 (t, J=8.1Hz, 2H), 2.04-2.15 (m, 4H), 1.70-1.77 (m, 2H), 1.25-1.38 (m, 6H), 0.89 (t, J=6.8Hz,3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|Source=
+|Chemical Synthesis=This compound was synthesized from arachidonyl chloride and ammonium hydroxide. Yield is 80 %. [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|Metabolism=
+|Biological Activity=Binding of this compound to the brain cannabinoid receptor (CBl),Ki (nM)>1000 [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
 }}
+{{Lipid/Footer}}

IDs and Links
LipidBank	XPR7022
LipidMaps	LMFA08010007
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}

mol	LBF20406AM06

LBF20406AM06: Difference between revisions

Latest revision as of 13:40, 21 October 2010

Navigation

Tools